Sharewise

26/05/2026

Regulatory clarity is built into Xenitra's digital asset strategy from the ground up.

Dr Anthony Noble, Non-Executive Chairman of Xenitra, explains how the company is navigating China's evolving digital asset landscape and cross-border e-commerce environment. Xenitra's tokens are built on the BNB blockchain under Hong Kong's tokenisation framework, reflecting its position as a Hong Kong-based cross-border e-commerce company. On the Australian side, the company has proactively taken steps to ensure full compliance with anticipated ASIC guidance, including preparing for a potential AFSL licence should it be required. With current utility and rewards tokens sitting comfortably within existing regulatory boundaries and a clear pathway mapped out for future trading and securitisation activity, Xenitra is operating under a well-understood scheme with compliance already built in.

25/05/2026

Is Metals Australia positioned to benefit from one of the biggest global shifts in critical minerals and battery supply chains?

As countries race to secure alternative sources outside of China, companies involved in graphite and battery materials could play a major role in the future of EVs and energy storage.

Metals Australia discusses the growing global push for supply chain security, government support, and what this could mean for the critical minerals sector moving forward.

25/05/2026

Funding the Araxá Project remains a key focus as development progresses.

With strong interest from global partners and governments, the strategy is to secure non-dilutive funding through grants, low-cost loans, and strategic partnerships. Early support from steel mills for the niobium side of the project could help accelerate development, while future cash flow may also contribute to funding the rare earths operation.

22/05/2026

Watch our webinar with Metals Australia, featuring CEO Paul Ferguson.

The webinar will commence with a presentation, followed by a live Q&A with the audience, providing you the opportunity to ask Paul any questions about MLS that you may have.

Key topics:
-Company overview & Introduction
-Project Portfolio – with core focus on the graphite project in Quebec, Canada

Watch now: https://hubs.la/Q04hBqyL0

Thank you Paul for joining us.

Watch our webinar with Metals Australia, featuring CEO Paul Ferguson.The webinar will commence with a presentation, followed by a live Q&A with the audience,...

19/05/2026

Today's Stock Spotlight is NYSE-listed The Walt Disney Company (NYSE:DIS).

Find out why we see growth potential in the stock and what key risks are involved.

Read here: https://hubs.la/Q04h3jJq0

19/05/2026

Today's Stock Spotlight is NYSE-listed Rocket Companies Inc. (NYSE:RKT).

Find out why we see growth potential in the stock and what key risks are involved.

Read here: https://hubs.la/Q04h3pzn0

19/05/2026

Today's Stock Spotlight is ASX-listed Aristocrat Leisure Ltd. (ASX:ALL).

Find out why we see growth potential in the stock and what key risks are involved.

Read here: https://hubs.la/Q04h38Zq0

19/05/2026

Today's Stock Spotlight is ASX-listed Xero Ltd. (ASX:XRO).

Find out why we see growth potential in the stock and what key risks are involved.

Read here: https://hubs.la/Q04h3nJ00

19/05/2026

A trillion-yuan partner and a sharper B2B focus are driving Xenitra's revenue growth.

Dr Anthony Noble, Non-Executive Chairman of Xenitra, unpacks the key drivers behind the company's recent revenue momentum and offtake agreement. Growth in the Nutritionals segment has been underpinned by a strategic relationship with Rockcheck Group, a multi-hundred billion dollar conglomerate diversifying from minerals and steel into healthcare and online pharmacy. By stripping out B2C complexity and focusing on large-scale B2B contracts, Xenitra has structured its Nutritionals business to service high-volume agreements with minimal staff and marketing overhead, a model well-suited to commoditised products operating on single-digit margins.

18/05/2026

🎥 Now on YouTube: Our full Stocks and Sips Q&A with Xenitra (ASX:XEN) is live.

Sharewise CEO Alex Perry sat down with Dr Anthony Noble, Non-Executive Chairman of Xenitra, for a candid conversation on how XEN is building an integrated digital commerce ecosystem across China - spanning nutraceuticals, OTC pharmaceuticals, and real-world-asset tokenisation through the OPAL token and Xen Shop.

Followed by live audience questions, the discussion covered:
▪️ Xenitra's three growth pillars and what the market may be underappreciating
▪️ The drivers behind $70m+ in sales since 2024 and the $30m offtake agreement
▪️ The Fukang OTC Pharmacy acquisition and China's cross-border pharmaceutical opportunity
▪️ Real-world asset tokenisation in practice and early commercial outcomes
▪️ Streamlining the nutritionals business under a leaner management structure

Watch the full Q&A → https://hubs.la/Q04gWMyb0

We were pleased to welcome Dr Anthony Noble, Non-Executive Chairman of Xenitra, for a full Q&A with Sharewise CEO Alex Perry, followed by live audience quest...

18/05/2026

The Araxá Project is shaping up to be a significant rare earth development with the potential to compete with established global producers.

With a resource comparable to Mountain Pass Mine and grades similar to Lynas Rare Earths, the project stands out for its high-grade mineralisation starting at surface, favourable logistics, and potential for a smaller environmental footprint.